A Study of IBI362 9 mg in Chinese Adults With Obesity
Clinical trial NCT06164873 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06164873
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-27
- Primary completion
- 2025-06-27
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.